These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 32742923)

  • 1. The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review.
    Vickman RE; Franco OE; Moline DC; Vander Griend DJ; Thumbikat P; Hayward SW
    Asian J Urol; 2020 Jul; 7(3):191-202. PubMed ID: 32742923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting benign prostate hyperplasia treatments: AR/TGF-β/NOX4 inhibition by apocynin suppresses inflammation and proliferation.
    Jin BR; Kim HJ; Na JH; Lee WK; An HJ
    J Adv Res; 2024 Mar; 57():135-147. PubMed ID: 37061215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.
    Nicholson TM; Sehgal PD; Drew SA; Huang W; Ricke WA
    Differentiation; 2013; 85(4-5):140-9. PubMed ID: 23792768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor roles in the development of benign prostate hyperplasia.
    Izumi K; Mizokami A; Lin WJ; Lai KP; Chang C
    Am J Pathol; 2013 Jun; 182(6):1942-9. PubMed ID: 23570837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting androgen receptor to suppress macrophage-induced EMT and benign prostatic hyperplasia (BPH) development.
    Lu T; Lin WJ; Izumi K; Wang X; Xu D; Fang LY; Li L; Jiang Q; Jin J; Chang C
    Mol Endocrinol; 2012 Oct; 26(10):1707-15. PubMed ID: 22915828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.
    Jin R; Strand DW; Forbes CM; Case T; Cates JMM; Liu Q; Ramirez-Solano M; Milne GL; Sanchez S; Wang ZY; Bjorling DE; Miller NL; Matusik RJ
    Prostate; 2021 Sep; 81(13):944-955. PubMed ID: 34288015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of
    Choi YJ; Kim EK; Fan M; Tang Y; Hwang YJ; Sung SH
    Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31591335
    [No Abstract]   [Full Text] [Related]  

  • 8. Personalized medicine for the management of benign prostatic hyperplasia.
    Bechis SK; Otsetov AG; Ge R; Olumi AF
    J Urol; 2014 Jul; 192(1):16-23. PubMed ID: 24582540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in the development of new drugs for treatment of benign prostatic hyperplasia.
    Kulig K; Malawska B
    Curr Med Chem; 2006; 13(28):3395-416. PubMed ID: 17168713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of combination of Stauntonia hexaphylla and Cornus officinalis on testosterone-induced benign prostatic hyperplasia through inhibition of 5α- reductase type 2 and induced cell apoptosis.
    Karunasagara S; Hong GL; Jung DY; Kim KH; Cho K; Jung JY
    PLoS One; 2020; 15(8):e0236879. PubMed ID: 32790676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic role of Glycyrrhiza Uralensis fisher on benign prostatic hyperplasia through 5 alpha reductase regulation and apoptosis.
    Park JY; Park WY; Park J; Ahn KS; Lee JH; Kwak HJ; Um JY
    Phytomedicine; 2022 Oct; 105():154371. PubMed ID: 35964456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of 5alpha-reductase in the treatment of benign prostatic hyperplasia.
    Tarter TH; Vaughan ED
    Curr Pharm Des; 2006; 12(7):775-83. PubMed ID: 16515494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benign prostatic hyperplasia: An overview of existing treatment.
    Dhingra N; Bhagwat D
    Indian J Pharmacol; 2011 Feb; 43(1):6-12. PubMed ID: 21455413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
    Bartsch G; Rittmaster RS; Klocker H
    World J Urol; 2002 Apr; 19(6):413-25. PubMed ID: 12022710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate of castration-induced prostate stroma regression is reduced in a mouse model of benign prostatic hyperplasia.
    Zhang R; Singh S; Pan C; Xu B; Kindblom J; Eng KH; Krolewski JJ; Nastiuk KL
    Am J Clin Exp Urol; 2023; 11(1):12-26. PubMed ID: 36923722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chrysophanic acid reduces testosterone-induced benign prostatic hyperplasia in rats by suppressing 5α-reductase and extracellular signal-regulated kinase.
    Youn DH; Park J; Kim HL; Jung Y; Kang J; Jeong MY; Sethi G; Seok Ahn K; Um JY
    Oncotarget; 2017 Feb; 8(6):9500-9512. PubMed ID: 27880726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased infiltrated macrophages in benign prostatic hyperplasia (BPH): role of stromal androgen receptor in macrophage-induced prostate stromal cell proliferation.
    Wang X; Lin WJ; Izumi K; Jiang Q; Lai KP; Xu D; Fang LY; Lu T; Li L; Xia S; Chang C
    J Biol Chem; 2012 May; 287(22):18376-85. PubMed ID: 22474290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoids are induced while dihydrotestosterone levels are suppressed in 5-alpha reductase inhibitor treated human benign prostate hyperplasia patients.
    Jin R; Forbes C; Miller NL; Strand D; Case T; Cates JM; Kim HH; Wages P; Porter NA; Mantione KM; Burke S; Mohler JL; Matusik RJ
    Prostate; 2022 Oct; 82(14):1378-1388. PubMed ID: 35821619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cynomorium songaricum Rupr demonstrates phytoestrogenic or phytoandrogenic like activities that attenuates benign prostatic hyperplasia via regulating steroid 5-α-reductase.
    Tao R; Miao L; Yu X; Orgah JO; Barnabas O; Chang Y; Liu E; Fan G; Gao X
    J Ethnopharmacol; 2019 May; 235():65-74. PubMed ID: 30708032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-dependent expression of the androgen receptor gene in the prostate and its implication in glandular differentiation and hyperplasia.
    Prins GS; Jung MH; Vellanoweth RL; Chatterjee B; Roy AK
    Dev Genet; 1996; 18(2):99-106. PubMed ID: 8934871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.